Active Equities Updates -- Research on Valero Energy, UTi Worldwide, SLM Corp., and Rexahn Pharma

LONDON, April 1, 2014 /PRNewswire/ --

The trading session on Monday, March 31, 2014 ended on a positive note as the Dow Jones Industrial Average finished at 16,457.66, up 0.82% and the NASDAQ Composite closed at 4,198.99, up 1.04%. The S&P 500 finished the session 0.79% higher at 1,872.34. The gains were broad based as nine out of ten sectors finished higher. During the session, gains in the Health Care, Materials, and Utilities sectors positively impacted the broader market. Investor-Edge looks at some of the equities which attracted the most attention and traded the most shares during the session. These include Valero Energy Corp. (NYSE: VLO), UTi Worldwide Inc. (NASDAQ: UTIW), SLM Corp. (NASDAQ: SLM) and Rexahn Pharmaceuticals Inc. (NYSE MKT: RNN). Free technical research on VLO, UTIW, SLM and RNN can be downloaded upon signing up at:

http://www.investor-edge.com/639-register


On Monday, Valero Energy Corp.'s shares recorded heavy trading as a total of 5.72 million shares changed hands, as compared with the three-month average volume of 8.43 million shares. The stock traded at an intraday trading range of $52.64 and $53.84, before closing the day at $53.10, up 0.45%. Valero Energy Corp.'s shares have declined 1.56% in the past three trading sessions, while the same has gained 10.67% in the last one month, and 5.36% on YTD basis. The S&P 500 Energy Sector Index mapped a gain of 2.28% in the previous one month, while the S&P 500 has gained 0.69% during the same period. The stock is trading above its 50-day and 200-day moving averages of $51.12 and $42.33, respectively. The stocks have a Relative Strength Index (RSI) of 51.04.  Sign up today to read free research on VLO at:

http://www.investor-edge.com/639-VLO-01Apr2014.pdf


UTi Worldwide Inc.'s stock saw heavy trading as a total of 5.75 million shares changed hands on Monday, as compared with the three-month average volume of 1.18 million shares. The stock ended the day at $10.59, down 5.95% and at an intraday range of $9.94 and $11.42. The company's shares have advanced 7.62% in the last one month, while the same has declined 4.59% in the previous three trading sessions and 39.69% on YTD basis. The S&P 500 Industrials Sector Index went up by 1.62% in the previous three trading sessions, while the NASDAQ Composite has advanced 0.61% during the same period. The stock is trading below its 50-day and 200-day moving averages of $13.73 and $15.46, respectively. The stock has an RSI of 37.53. On the same day, UTi Worldwide Inc. announced its FY 2014 and Q4 FY 2014 financial results (period ended January 31, 2014). For Q4 FY 2014, the company reported net loss attributable to  UTi Worldwide Inc. of $50.72 million, or $0.48 per diluted share. For FY 2014, the company reported net loss attributable to UTi Worldwide Inc. of $76.66 million, or $0.73 per diluted share. Sign up today to read free research on UTIW at:

http://www.investor-edge.com/639-UTIW-01Apr2014.pdf


Shares in SLM Corp. registered heavy trading as a total of 5.79 million shares changed hands, against a three-month average volume of 4.64 million shares. On Monday, the stock finished the day at $24.48, down 0.49% and at an intraday range of $24.43 and $24.84. The stock traded at a PE ratio of 7.98. SLM Corp.'s shares have gained 2.26% in the last one month, while the same has declined 1.73% in the past three trading sessions and 6.85% on YTD basis. The S&P 500 Financials Sector Index mapped a gain of 3.08% in the last one month, while the NASDAQ Composite has declined 2.53% during the same period. The stock is trading above its 50-day moving average of $24.00. Additionally, the stock has an RSI of 49.27. Sign up today to read free research on SLM at:

http://www.investor-edge.com/639-SLM-01Apr2014.pdf


Shares in Rexahn Pharmaceuticals Inc. saw heavy trading as a total of 5.83 million shares were exchanged, against a three-month average volume of 12.05 million shares. On Monday, the stock closed the day at $1.08, down 5.26% and with an intraday fluctuation between $1.07 and $1.16. Rexahn Pharmaceuticals Inc.'s shares have fallen by 4.42% in the previous three trading sessions, 20.00% in the last one month, while the stock has rallied 111.76% on YTD basis. The S&P 500 Health Care Sector Index have edged 0.74% higher in the previous three trading sessions, while the S&P 500 Index gained 1.07% during the same period. The stock is trading above its 200-day moving average of $0.66. The company's shares have an RSI of 42.56. Sign up today to read free research on RNN at:

http://www.investor-edge.com/639-RNN-01Apr2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://Investor-Edge.com

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED